THIER Appoints Ian Hunter as Independent Non-Executive Director to Drive Strategic Growth and Investment
THIER Appoints Ian Hunter as Independent Non-Executive Director to Drive Strategic Growth and Investment
THIER Appoints Ian Hunter as Independent Non-Executive Director to Drive Strategic Growth and Investment 🚀
THIER, a digital health start-up dedicated to preventing lifestyle-related diseases 🏥, is pleased to announce that Ian Hunter has joined its Board of Directors as an Independent Non-Executive Director, effective September 25, 2024. Ian’s appointment reinforces THIER’s commitment to advancing its strategic growth initiatives 📈 and strengthening its investment readiness 💰 as it continues to develop its innovative health solutions.
Ian Hunter brings over 20 years of experience in corporate finance, business development, and strategic advisory 🌍. With a distinguished career spanning technology, finance, and real estate, Ian has facilitated millions of dollars in funding through equity, debt, and asset finance. His extensive network of institutional investors, family offices, and venture capitalists, combined with his expertise in corporate governance and business growth strategies, positions him as a key asset to THIER’s mission.
Currently, Ian serves as the Group CEO of RHF, where he leads divisions focused on funding and business growth strategies, particularly in disruptive technology sectors ⚡. As CEO of HuntFunding, Ian specialises in ensuring companies are “investment-ready,” and he has held advisory roles for businesses in diverse sectors. His prior experience includes serving as Non-Executive Director at Imperial Corporate Capital PLC and driving a strategic turnaround at IMRG, where he increased membership and revenue by 40% during the recession 🔑.
Kofo Mary Are, shared:
"We are thrilled to welcome Ian Hunter to THIER’s Board. Ian’s extensive expertise in corporate funding, coupled with his proven track record in business growth, will be invaluable as we scale THIER and attract investors who believe in our vision. His insight into strategic growth and investment readiness aligns perfectly with our mission to bring AI-driven health solutions to prevent lifestyle diseases." 🤝✨
Ian Hunter shared:
"I am honoured to join THIER’s Board at this exciting time. THIER’s dedication to digital health innovation and disease prevention is inspiring, and I look forward to contributing to its growth journey and helping it secure the resources needed to expand its impact." 🌍
About THIER
THIER is an AI-driven mobile platform 🤖📱 dedicated to preventing obesity and type II diabetes by equipping organizations with tools to foster healthier employee lifestyles 🌿.
Designed for Heads of Wellness, Heads of HR, and Heads of Occupational Health, THIER provides solutions for companies across diverse sectors, including:
- Manufacturing 🏭
- Healthcare 🏥
- Technology 💻
- Financial Services 💰
- Energy ⚡
- Transportation 🚛
By combining machine learning algorithms 🧠, community support 🤝, and personalized health interventions 🩺, THIER’s platform enables effective disease prevention. All data is securely managed on blockchain technology 🔒, ensuring data integrity and privacy.
Discover more about THIER’s transformative approach:
- 🌐 Visit our website: www.thier.io
- 🎥 Watch our introductory video: [Link to Video]
🤝 Interested in supporting early-stage digital health innovation as an investor? Connect with us here: 👈 😀
💡 Note: THIER holds SEIS and EIS assurance, offering tax benefits for eligible investors.
Contact Information:
📧 THIER Communications Team: Press@thier.io
***********
The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may","will", "should", "expect","anticipate", "project", "estimate","intend", "continue", "target","believe" (or the negatives thereon) or other variations thereon or comparable terminology.
These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends n its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions. Considering these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.
The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.
